Position in URGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$15,717,684
-$3,192,115 QoQ
Shares Held
874,176
+8.3% QoQ
Ownership
1.79%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 9%
Shared 0%
None 91%
Common Shares in URGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026STATE STREET CORP holds $30,291,958,108 across 423 Biotechnology names. URGN ranks #161 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,730,139 | $5,237,976,269 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,664,478 | $3,603,962,281 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,322,698 | $1,099,381,087 | |
| 4 | INSM |
INSMED Inc
|
5,551,699 | $907,813,820 | |
| 5 | INCY |
Incyte Corp
|
9,641,384 | $907,447,062 | |
| 6 | MRNA |
Moderna, Inc.
|
14,861,409 | $754,959,577 | |
| 7 | RPRX |
Royalty Pharma plc
|
10,989,851 | $527,183,152 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
16,186,613 | $448,369,180 |
All Filings in URGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $15,717,684 | 874,176 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $18,909,799 | 807,421 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $16,347,947 | 819,446 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $11,064,640 | 807,638 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $8,792,832 | 795,012 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $8,605,764 | 808,053 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $9,773,704 | 769,583 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $12,193,623 | 726,676 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $8,054,910 | 536,994 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $7,362,465 | 490,831 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $6,361,997 | 454,104 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $4,337,115 | 419,045 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,110,851 | 120,222 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $998,673 | 112,590 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $853,482 | 102,582 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $1,110,735 | 135,621 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $4,775,179 | 548,241 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,815,436 | 506,355 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $8,607,231 | 511,726 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $7,287,729 | 477,258 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $8,597,283 | 441,339 | Shares | Defined | 2021-07-09 | |
| 2020-12-31 | $7,936,206 | 440,411 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $7,975,836 | 413,470 | Shares | Defined | 2020-11-10 | |
| 2020-06-30 | $11,106,250 | 425,201 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $7,067,226 | 396,145 | Shares | Defined | 2020-06-19 | |
| No filing history on record for this holder in this stock. | ||||||